$93.61
-13.75-12.81%
al cierre: Aug 26, 5:00 PM EST
$93.71
0.110.11%
After hour: 5:15 PM EST
Spyre Therapeutics Inc
SYRENASDAQ
PRO
Spyre Therapeutics Earnings & Forecasts
Spyre Therapeutics (SYRE) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Spyre Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.74 | $-0.66 | $-0.74 | $-0.72 |
| Actual | $-0.36 | $-0.74 | $-0.70 | $-0.15 |
| Surprise | +51.3% | -12.1% | +5.41% | +79.2% |
| Revenue | ||||
| Estimate | — | — | $111110 | — |
| Actual | $0 | $0 | $0 | — |
| Surprise | — | — | -100.0% | — |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.81 | $-0.84 | $-0.88 | $-0.85 |
| Revenue | ||||
| Consensus | — | — | — | — |